| Typicality: | 0.551 |
| Saliency: | 0.327 |
| to receive placebo | 12 | purpose |
| to serelaxin | 8 | other |
| within each group | 5 | location |
| subject → be randomized in → a 1:1 ratio | 13 |
| subject → be randomized → 1:1 | 10 |
| subject → be randomized → 2:1 | 7 |
| subject → be randomized in → a 2:1 ratio | 4 |
| subject → randomize → 1:1 | 3 |
| negative | neutral | positive |
| 0.074 | 0.884 | 0.042 |
| Raw frequency | 37 |
| Normalized frequency | 0.327 |
| Modifier score | 1.000 |
| Perplexity | 7.686 |